Days like today act as a good audit of your process.
Were the entries low-risk enough that you can sit through the noise, or did you FOMO into positions out of excitement?
A good entry doesn’t just improve your risk/reward, it also buys time, patience, and the ability to let the trade work.
Where you entered determines how much noise one can afford to sit through.
The U.S. Treasury is doubling long-end bond buybacks as it moves to shore up liquidity in one of the most pressured parts of the market.
Starting Sept. 9 buybacks for 10–20Y and 20–30Y Treasuries will rise from $2B to at least $4B per operation.
It’s never been easier to design your dream house.
Draw a shape. Define your rooms. Set your constraints.
@DraftedAI generates complete floor plans, elevations, and 3D home designs in seconds.
Over the last month, 120,000 people generated 325,000+ home designs with https://t.co/XqC0LP5n3y.
SpaceX ($SPCX) lockup schedule 🚀
📅 Aug 6: First tranche opens (~20% of restricted shares, ~2 days after Q2 earnings)
📅 Aug–Oct: Smaller tranches every 2-4 wks
📅 After Q3 earnings: ~28% tranche
📅 Dec 8: Final 180-day lockup expires
📅 June 2027: Musk’s ~6.4B share block unlocks
First Goldman Sachs, now Fidelity. Wall Street’s biggest heavyweights are publicly backing CLARITY.
Major financial firms recognize that a clear, comprehensive market structure benefits everyone—from retail investors to institutional capital.
Who's next?
CURRENTLY ONLY 5% OF SPACEX SHARES ARE AVAILABLE TO BE TRADED
20% OF SHARES UNLOCK 2 DAYS AFTER EARNINGS AUG 6
ANOTHER 10% WILL UNLOCK IF SHARES ARE OVER $175
ADDITIONAL 7% UNLOCKS AROUND AUG 21 AND AGAIN SEPT 10
BE PREPARED CAUSE THE REAL PRICE DISCOVERY STARTS AUG 6
$SPCX
I'm a cardiologist. Everyone is sharing this study as a skin story. They're burying the part that matters.
Scientists took the aorta of a 75-year-old donor, applied a single engineered enzyme, and stripped away more than 70% of the molecular damage — bringing it down to the levels you'd see in a 30-year-old artery.
Published five days ago in Nature Communications. Revel Pharmaceuticals, with Calico and the University of Colorado.
Here's what they erased.
Sugar reacts with proteins in your body the same way heat browns bread — slowly, over a lifetime. It leaves behind a residue called CML, the most abundant advanced glycation end product in aging tissue. It welds itself onto collagen and elastin in your skin, your eye lens, and your arterial walls.
Two things follow. Your arteries stiffen. And CML latches onto a receptor called RAGE, which drives chronic inflammation — the exact fire I've been writing about for months as the engine of heart disease.
Since the 1980s this damage was considered permanent. Your body has no enzyme to remove it. Every existing approach only slows new damage from forming. Nothing touched what was already there.
So they built an enzyme that doesn't exist in nature. They screened 45,000 protein structures, then ran five rounds of directed evolution across more than 500 million variants until they had CMLase — a molecular lawnmower that oxidizes the CML off the protein and restores the original, healthy lysine underneath.
Not patched. Reversed.
Over 70% cleared from elderly arterial tissue. Over 55% from elderly skin — below the levels found in 31-year-old skin. 45-78% in lens proteins. The CEO said they expected 20% and were floored.
Arterial stiffness drives systolic hypertension, heart failure, and stroke, and I have no drug that reverses it. I can slow the process. I cannot undo it. This paper says undoing it may be possible.
The caveats are real and I won't skip them. This was done on donated tissue in a dish, not in a living person. No functional data yet — we don't know if that artery got measurably more elastic. Delivering a large enzyme deep into human tissue is a hard, unsolved problem. Clinical trials are years away.
But something considered permanent for forty years just came off human tissue.
We spent a century learning to slow aging. Someone finally figured out how to erase it.
Thank you @theallinpod@friedberg@chamath@pesottas
$AVGO
FVE: $590
Broadcom is the hyperscalers' path to building more efficient and cost effective AI chips.
For the full report: https://t.co/ZZkcDZXBMM
Great advice: do more
Also great advice: do less
How do you make sense of it?
Do more of fewer.
“Perfect every detail. Limit the number of details.” -Jack Dorsey
Brilliant idea. Imagine a future of abundance and happiness and win millions of dollars in prizes. Anyone can do this. Kids can do this too. There should be no excuses. Disregard the naysayers.
Stories shape our future. Story tellers manifest our destiny. Someone, somewhere, is writing an epic screenplay that is more Star Trek, than Terminator. A vision of a compelling and optimistic tomorrow that will shape humanity’s next few decades.
The cell phone, the internet, humanoid robots, self-driving cars, voice assistants, and Starships were all imagined in science fiction before they were built by engineers. Stories are blueprints.
Question: What if we asked storytellers around the world to envision an epic and compelling future for humanity, and then funded them to produce that film? What if we could flood the world with positive visions of the future, rather than dystopian predictions?
Announcing the Future Vision XPRIZE 🧵
$IREN - The Moat
IREN Limited has secured a larger power supply than any of its competitors, and when Sweetwater 1 becomes operational, they will have an operational power supply of 2.2 GW (Bitdeer, the current leader, has 1.66 GW).